Synevo
Sign up for
HPV DNA 14 qualitative high-oncogenic genotypes

HPV DNA 14 qualitative high-oncogenic genotypes

The test detects the presence of DNA from 14 high-risk oncogenic genotypesó (16, 18, 31, 33, 35, 39, 45, 51, 52, 56, 58, 59, 66 and 68) of human papillomavirus (HPV)

PLN 235.00 PLN 224.00Lowest price from 30 days before discounting PLN 224.00

Available in stock

Fast turnaround time

Safe courier delivery

Convenience and comfort shopping

Fast shipping

Direct from the manufacturer

Secure payments

BLIK, Przelewy24

Test description

HPV infections are among the most common sexually transmitted diseases. Of the several hundred existing types of the virus, most cause harmless, spontaneously resolving infections or the presence of so-called condylomata.

The virus is also known as "condylomata"

However, a dozen of them, show highly oncogenic activity, that is, increasing the risk of cancerous lesions. HPV types 16 and 18, which are most commonly detected in Polish patients, are responsible for about 70% of all cases of cervical cancer.

The HPV types 16 and 18, which are most commonly detected in Polish patients, are responsible for about 70% of all cases of cervical cancer

The HPV viruses endowed with high oncogenic potential lead to the development of dysplastic lesions (CIN) and are mainly detected in cervical cancer cells (more than 90%). Persistent infection with any of the highly oncogenic HPV types poses a high risk of cancer. The most oncogenic type of the virus is HPV16, which is collectively responsible for about 55-60% of all cases of cervical cancer.

The most common genotypes in the population are HPV types 6 and 11. These lesions can appear weeks or months after contact with an infected person. Treatment is lengthy and, unfortunately, often has to be repeated due to recurrences.

Treatment is also lengthy

Documents